Robinson Gertraud W, Kang Keunsoo, Yoo Kyung Hyun, Tang Yong, Zhu Bing-Mei, Yamaji Daisuke, Colditz Vera, Jang Seung Jian, Gronostajski Richard M, Hennighausen Lothar
Laboratory of Genetics and Physiology (G.W.R., K.K., K.H.Y., Y.T., D.Y., V.C., S.J.J., L.H.), National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892; Department of Microbiology (K.K.), Dankook University, Cheonan 330-714, Republic of Korea; Chengdu University of Traditional Chinese Medicine (Y.T.), Chengdu 610072, Republic of China; Key Laboratory of Acupuncture and Medicine (B.-M.Z.), Nanjing University of Traditional Chinese Medicine, Nanjing 210046, Republic of China; and New York State Center of Excellence in Bioinformatics and Life Sciences (R.M.G.), Department of Biochemistry, Developmental Genomics Group, University at Buffalo, Buffalo, New York 14203.
Mol Endocrinol. 2014 May;28(5):758-67. doi: 10.1210/me.2012-1387. Epub 2014 Mar 28.
Mammary-specific genetic programs are activated during pregnancy by the common transcription factor signal transducer and activator of transcription (STAT) 5. More than one third of these genes carry nuclear factor I/B (NFIB) binding motifs that coincide with STAT5 in vivo binding, suggesting functional synergy between these two transcription factors. The role of NFIB in this governance was investigated in mice from which Nfib had been inactivated in mammary stem cells or in differentiating alveolar epithelium. Although NFIB was not required for alveolar expansion, the combined absence of NFIB and STAT5 prevented the formation of functional alveoli. NFIB controlled the expression of mammary-specific and STAT5-regulated genes and chromatin immunoprecipitation-sequencing established STAT5 and NFIB binding at composite regulatory elements containing histone H3 lysine dimethylation enhancer marks and progesterone receptor binding. By integrating previously published chromatin immunoprecipitation-sequencing data sets, the presence of NFIB-STAT5 modules in other cell types was investigated. Notably, genomic sites bound by NFIB in hair follicle stem cells were also occupied by STAT5 in mammary epithelium and coincided with enhancer marks. Many of these genes were under NFIB control in both hair follicle stem cells and mammary alveolar epithelium. We propose that NFIB-STAT5 modules, possibly in conjunction with other transcription factors, control cell-specific genetic programs.
乳腺特异性基因程序在孕期由共同转录因子信号转导子及转录激活子(STAT)5激活。这些基因中超过三分之一带有核因子I/B(NFIB)结合基序,其在体内与STAT5的结合位点重合,提示这两种转录因子之间存在功能协同作用。研究人员在乳腺干细胞或分化中的肺泡上皮细胞中使Nfib失活的小鼠体内,研究了NFIB在这一调控过程中的作用。虽然肺泡扩张并不需要NFIB,但NFIB和STAT5共同缺失会阻止功能性肺泡的形成。NFIB控制乳腺特异性及STAT5调控基因的表达,染色质免疫沉淀测序确定了STAT5和NFIB在含有组蛋白H3赖氨酸二甲基化增强子标记和孕激素受体结合位点的复合调控元件上的结合。通过整合先前发表的染色质免疫沉淀测序数据集,研究了其他细胞类型中NFIB-STAT5模块的存在情况。值得注意的是,毛囊干细胞中与NFIB结合的基因组位点在乳腺上皮细胞中也被STAT5占据,且与增强子标记重合。这些基因中的许多在毛囊干细胞和乳腺肺泡上皮细胞中均受NFIB调控。我们提出,NFIB-STAT5模块可能与其他转录因子共同控制细胞特异性基因程序。